Reactin-Plus 10 Tablets

babies: not applicable. lactating mothers: it is safe to use this medication in breastfeeding.
pregnancy: it is unsafe to use this medication in pregnancy. limited studies showed that drugs affect the developing fetus.
consult your doctor before using this medicine. driving: diclofenac sodium and paracetamol tablet may decrease alertness, affects vision and may cause dizziness and sleep.
do not drive if these symptoms occur. alcohol: avoid consumption of alcohol while taking diclofenac sodium and paracetamol tablet.
kidney: diclofenac sodium and paracetamol tablet should be used with caution in patients with kidney disease. dosage adjustment may be required.
seek a doctor’s advice before using this medication. liver: diclofenac sodium and paracetamol tablet should be used with caution in patients with liver disease.
dosage adjustment may be required. seek a doctor’s advice before using this medication..

Nausea Vomiting Stomach pain Heartburn Diarrhea Loss of appetite.

REACTIN PLUS tablet is a painkiller used to treat rheumatoid arthritis, spondylitis and osteoarthritis it works by blocking the action of chemical messengers responsible for pain, fever and inflammation.

if you miss a dose of Reactin plus take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• REACTIN PLUS tablet is a painkiller used to treat rheumatoid arthritis, spondylitis and osteoarthritis • it works by blocking the action of chemical messengers responsible for pain, fever and inflammation • take this medication with food. swallow the tablet as a whole with a glass of water, do not break or chew the tablet • avoid consumption of alcohol while taking REACTIN PLUS tablet • before taking this medication, inform your doctor if you are pregnant or intend to be pregnant, or have kidney, heart and liver problems & stomach ulcers and using any other medications.

• diclofenac sodium + abametapir: concurrent use leads to an increase in the serum concentration of diclofenac sodium • diclofenac sodium + abiraterone: concurrent use leads to an increase in the serum concentration of diclofenac sodium • paracetamol + abciximab: concurrent use leads to an increase in the risk or severity of bleeding and haemorrhage • diclofenac sodium +abcavir: concurrent use leads to a decrease in the excretion rate of diclofenac sodium • paracetamol + acebutolol: concurrent use leads to a decrease in the antihypertensive activity of acebutolol.